CompanyDrug

Innovent Biologics Launches Phase I Study for IBI3002, a Bispecific Antibody Targeting Asthma

CompanyDrug

CDE Grants Priority Review to Jiu An’s Adrenaline and AnHeart’s Taletrectinib; Two Others Earn Breakthrough Therapy Designation

CompanyLegal / IP

Sandoz Agrees to $265 Million Settlement in U.S. Generic Drug Antitrust Case

CompanyDrug

Huadong Medicine’s MaiLi Extreme Achieves Clinical Study Milestone for Chin Retraction Treatment

CompanyMedical Device

ARSMO Plastic Aesthetic Hospital Introduces Liquid PCL Implant GOURI in Hainan

CompanyDrug

CARsgen Therapeutics’ BCMA-targeted CAR-T Cell Therapy Approved by China’s NMPA